2022
DOI: 10.1002/jhet.4599
|View full text |Cite
|
Sign up to set email alerts
|

Iron‐catalyzed construction of cyanomethylated thiohydantoins by cross‐dehydrogenative C(sp3)‐C(sp3) coupling

Abstract: The efficient and novel approach for synthesizing cyanomethylated thiohydantoin from readily obtainable acetonitrile and 1,3-dibenzyl-2-thiohydantoin through iron(II)-catalyzed cross dehydrogenative coupling (CDC) protocol is documented here. The strategy displays extensive substrate scope, and provides an effectual construction of cyanomethylated thiohydantoins in moderate to good yield. Prominently, this new methodology represents hitherto unobserved reactivity pattern for the thiohydantoin.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…They are found as active nuclei in anticancer, antimalaria, anticonvulsant, antiparasitic, and antibacterial compounds, as well as in tyrosine inhibitors (Scheme 1c). [19][20][21] Consequently, the development of synthetic routes to such fused heterocycles is desirable.…”
mentioning
confidence: 99%
“…They are found as active nuclei in anticancer, antimalaria, anticonvulsant, antiparasitic, and antibacterial compounds, as well as in tyrosine inhibitors (Scheme 1c). [19][20][21] Consequently, the development of synthetic routes to such fused heterocycles is desirable.…”
mentioning
confidence: 99%